{
  "id": "6440393157b1c7a31500004a",
  "type": "factoid",
  "question": "Which year was XIPERE approved by the FDA?",
  "ideal_answer": "XIPERE was approved by the FDA in 2021.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/35868358"
  ],
  "snippets": [
    {
      "text": "Drug delivery to the suprachoroidal space (SCS\u00ae) has become a clinical reality after the 2021 FDA approval of CLS-TA, a triamcinolone acetonide injectable suspension for suprachoroidal use (XIPERE\u00ae), administered via a microneedle-based device, the SCS Microinjector\u00ae. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35868358",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "2021"
}